AVANIR Pharmaceuticals (NASDAQ:AVNR)
A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
headyinvestor
(91.33)
Submitted: 4/11/2012 8:43:27 AM :
Start Price:
$3.14
AVNR Score:
+17.62
This company is trading at 50x revenue! Really!?
Recs
portefeuille
(99.78)
Submitted: 12/15/2011 9:36:42 PM :
Start Price:
$3.28
AVNR Score:
-56.35
There are currently 2300 AVNR shares in my "fund" with break-even of around 2.30 USD.
http://caps.fool.com/Blogs/fund-trades/678775.
Recs
1stMartian
(< 20)
Submitted: 12/6/2011 1:25:08 PM :
Start Price:
$2.50
AVNR Score:
+1.47
Declining sales, declining cash flow, horrible ROI.
Recs
Recs
dgoldmeier
(< 20)
Submitted: 2/9/2011 5:23:42 PM :
Start Price:
$4.02
AVNR Score:
-45.69
If sales on Nuxedta go well this company can hit a homerun. Well worth the risk.
Recs
bw64588
(< 20)
Submitted: 2/8/2011 6:20:12 AM :
Start Price:
$4.18
AVNR Score:
-48.33
AVNR is going to surprise everyone. I look for it to start running in March when we hear the first reports of sales figures for Neudexta.
Recs
Ooker
(64.61)
Submitted: 12/17/2010 3:43:45 PM :
Start Price:
$3.98
AVNR Score:
-52.46
Throwing darts at this point. Numbers look good, 100M OS, inside and institutional look great for a 4-dollar stock.
Recs
peter1568
(< 20)
Submitted: 11/25/2010 12:28:41 PM :
Start Price:
$4.30
AVNR Score:
-64.24
avnr is a takeover target for big business, has approved drug, little or no debt and enough money for its production and distribution, I believe that large company that already has spoken waiting for the Q4 11/30/2010 to offer for the shares, the next month I see some of these big companies could get started talking to avnr to buy next year
Recs
upordownimup
(< 20)
Submitted: 11/16/2010 3:21:12 PM :
Start Price:
$4.60
AVNR Score:
-70.85
New drug approved in hostile climate for new drugs. I think Abreva works like magic. Love their discovery method.
Recs
BadCopNoDonuts
(< 20)
Submitted: 11/1/2010 11:52:45 AM :
Start Price:
$5.10
AVNR Score:
+76.40
I just bought March Puts for cheap. Kind of a no-brainer.
Recs
BioInvestor217
(< 20)
Submitted: 9/29/2010 12:08:15 AM :
Start Price:
$3.32
AVNR Score:
-47.66
Solid fundamentals and very good drug pipeline. See below for more info on their drug AVP-923 which is due for FDA review October 30th 2010. Expect to see major run-up and positive news. Conserative target before news: $4.25-$4.50. Clinical tests and trials look good, overall very good outlook.
"AVANIR is developing AVP-923 for use in PBA (also known as involuntary emotional expression disorder (IEED) and emotional lability) and diabetic peripheral neuropathic pain."
Recs
ebitdat
(20.32)
Submitted: 9/16/2010 8:16:26 PM :
Start Price:
$2.72
AVNR Score:
-27.67
Expect a run-up to approval date
Recs
venkybt
(< 20)
Submitted: 7/13/2010 2:24:37 PM :
Start Price:
$3.51
AVNR Score:
-59.34
As a new drug in the market with good safety profile always clicks,,,,,
Recs
Cosmo21
(< 20)
Submitted: 6/12/2010 7:03:08 PM :
Start Price:
$2.75
AVNR Score:
-32.35
Approval coming soon. Potential 9 $ stock.
Recs
LonWa
(< 20)
Submitted: 5/29/2010 10:46:01 AM :
Start Price:
$2.38
AVNR Score:
-16.89
Looks good but will hold off buying for now, think it will go down a little more before it starts to move up.
Recs
zandi561
(< 20)
Submitted: 5/26/2010 1:26:31 PM :
Start Price:
$2.43
AVNR Score:
-19.02
This time around it is expected that Avanir got it right with Zenvia. Lower dosage still maintains strong efficacy. FDA concern about patients overdosing has been addressed through lower dosage. QT levels are normalized after homeostasis.
Recs
jstonelake
(< 20)
Submitted: 3/31/2010 2:48:36 PM :
Start Price:
$2.40
AVNR Score:
-6.54
AVNR has had many ups & downs, now they are on the upside !
Recs
sempire
(< 20)
Submitted: 8/11/2009 3:16:17 PM :
Start Price:
$2.82
AVNR Score:
-52.75
Looking good so far as the FDA is concerned, and continued R&D will prove to be valuable for this stock. Looking for interest from the big boys.
Recs
Recs
bahlmann
(< 20)
Submitted: 7/13/2009 10:55:25 AM :
Start Price:
$1.88
AVNR Score:
-13.77
A history of large swings
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 35 : 1 2 Next »